Literature DB >> 12493264

Risk factors for recurrence of primary sclerosing cholangitis of liver allograft.

Alonso Vera1, Shazma Moledina, Bridget Gunson, Stefan Hubscher, Darius Mirza, Simon Olliff, James Neuberger.   

Abstract

Primary sclerosing cholangitis (PSC) is a disease of unknown cause that effects the biliary tree and is closely associated with inflammatory bowel disease. We did a retrospective analysis of the risk factors associated with recurrence of PSC in an allograft after liver transplantation. Recurrence of disease, assessed by liver histology or imaging the biliary tree, occurred in 56 of 152 patients (37%) at a median of 36 months (range 1.4-120 months). Multivariate analysis showed that being male (relative risk 1.2, 95% CI 0.73-2.15) and an intact colon before transplantation (8.7, 1.19-64.48) were associated with recurrence. These observations could help elucidate the pathogenesis of the disease.

Entities:  

Mesh:

Year:  2002        PMID: 12493264     DOI: 10.1016/S0140-6736(02)11861-7

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  42 in total

Review 1.  Developments in liver transplantation.

Authors:  J Neuberger
Journal:  Gut       Date:  2004-05       Impact factor: 23.059

2.  Current status of therapy in autoimmune liver disease.

Authors:  Gideon M Hirschfield; Nadya Al-Harthi; E Jenny Heathcote
Journal:  Therap Adv Gastroenterol       Date:  2009-01       Impact factor: 4.409

Review 3.  Gastroenterology services in the UK. The burden of disease, and the organisation and delivery of services for gastrointestinal and liver disorders: a review of the evidence.

Authors:  J G Williams; S E Roberts; M F Ali; W Y Cheung; D R Cohen; G Demery; A Edwards; M Greer; M D Hellier; H A Hutchings; B Ip; M F Longo; I T Russell; H A Snooks; J C Williams
Journal:  Gut       Date:  2007-02       Impact factor: 23.059

Review 4.  Update in the Care and Management of Patients with Primary Sclerosing Cholangitis.

Authors:  Mai Sedki; Cynthia Levy
Journal:  Curr Gastroenterol Rep       Date:  2018-06-09

5.  Primary sclerosing cholangitis: The importance of treating stenoses and infections.

Authors:  Jens J W Tischendorf; Ramin Schirin-Sokhan
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-12       Impact factor: 46.802

Review 6.  Analytical review of diagnosis and treatment strategies for dominant bile duct strictures in patients with primary sclerosing cholangitis.

Authors:  Murad Aljiffry; Paul D Renfrew; Mark J Walsh; Marie Laryea; Michele Molinari
Journal:  HPB (Oxford)       Date:  2011-02       Impact factor: 3.647

Review 7.  Role of colectomy in preventing recurrent primary sclerosing cholangitis in liver transplant recipients.

Authors:  Bettina M Buchholz; Panagis M Lykoudis; Reena Ravikumar; Joerg M Pollok; Giuseppe K Fusai
Journal:  World J Gastroenterol       Date:  2018-07-28       Impact factor: 5.742

Review 8.  Primary sclerosing cholangitis as an intractable disease.

Authors:  Sumihito Tamura; Yasuhiko Sugawara; Norihiro Kokudo
Journal:  Intractable Rare Dis Res       Date:  2012-02

Review 9.  Primary sclerosing cholangitis: diagnosis and treatment.

Authors:  Holger Lutz; Christian Trautwein; Jens W Tischendorf
Journal:  Dtsch Arztebl Int       Date:  2013-12-23       Impact factor: 5.594

10.  Leukocytapheresis Therapy Improved Cholestasis in a Patient Suffering from Primary Sclerosing Cholangitis with Ulcerative Colitis.

Authors:  Minoru Itou; Keiichi Mitsuyama; Takumi Kawaguchi; Yoshinobu Okabe; Hideya Suga; Junya Masuda; Hiroshi Yamasaki; Kotaro Kuwaki; Eitaro Taniguchi; Masaru Harada; Osamu Tsuruta; Michio Sata
Journal:  Case Rep Gastroenterol       Date:  2009-04-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.